Bryn Mawr Capital Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $275K | Sell |
706
-633
| -47% | -$246K | 0.02% | 355 |
|
|
2025
Q1 | $582K | Sell |
1,339
-904
| -40% | -$393K | 0.03% | 241 |
|
|
2024
Q4 | $827K | Buy |
2,243
+1
| +0% | +$369 | 0.04% | 234 |
|
|
2024
Q3 | $1.17M | Sell |
2,242
-42
| -2% | -$21.8K | 0.06% | 200 |
|
|
2024
Q2 | $1.24M | Buy |
2,284
+5
| +0.2% | +$2.71K | 0.07% | 195 |
|
|
2024
Q1 | $1.18M | Sell |
2,279
-160
| -7% | -$83K | 0.07% | 207 |
|
|
2023
Q4 | $1.15M | Sell |
2,439
-85
| -3% | -$40.1K | 0.07% | 199 |
|
|
2023
Q3 | $1.1M | Buy |
2,524
+8
| +0.3% | +$3.48K | 0.07% | 200 |
|
|
2023
Q2 | $1.12M | Buy |
2,516
+127
| +5% | +$56.4K | 0.11% | 158 |
|
|
2023
Q1 | $1.1M | Sell |
2,389
-75
| -3% | -$34.5K | 0.11% | 153 |
|
|
2022
Q4 | $1.26M | Buy |
+2,464
| New | +$1.26M | 0.14% | 134 |
|